LifeMD Financial Statements From 2010 to 2026

LFMD Stock

USD 4.03 0.10 2.54%

LifeMD's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing LifeMD's valuation are provided below:

Gross Profit

217.2 M

Profit Margin

(0.03)

Market Capitalization

203.1 M

Enterprise Value Revenue

0.7413

Revenue

250.1 M

There are over one hundred nineteen available fundamental ratios for LifeMD, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of LifeMD's last-minute performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 265.6 M. The current year's Enterprise Value is expected to grow to about 252.2 M

LifeMD Total Revenue

256.54 Million

Check LifeMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifeMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.5 M, Interest Expense of 2.6 M or Selling General Administrative of 87.7 M, as well as many indicators such as Price To Sales Ratio of 1.05, Dividend Yield of 0.0138 or Days Sales Outstanding of 22.78. LifeMD financial statements analysis is a perfect complement when working with LifeMD Valuation or Volatility modules.

Build AI portfolio with LifeMD Stock

Check out the analysis of LifeMD Correlation against competitors.

LifeMD Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

87.5 M

83.3 M

23.6 M

Slightly volatile

Short and Long Term Debt Total

30.3 M

28.9 M

6.6 M

Slightly volatile

Other Current Liabilities

22.4 M

21.3 M

5.7 M

Slightly volatile

Total Current Liabilities

72.8 M

69.3 M

18.5 M

Slightly volatile

Property Plant And Equipment Net

9.5 M

9.1 M

1.9 M

Slightly volatile

Accounts Payable

19.3 M

18.4 M

5.9 M

Slightly volatile

Cash

42.3 M

40.3 M

12.2 M

Slightly volatile

Cash And Short Term Investments

42.3 M

40.3 M

12.2 M

Slightly volatile

Net Receivables

9.9 M

9.5 M

2.3 M

Slightly volatile

Common Stock Total Equity

377.1 K

362.9 K

337.2 K

Slightly volatile

Common Stock Shares Outstanding

49.7 M

47.4 M

18.7 M

Slightly volatile

Liabilities And Stockholders Equity

87.5 M

83.3 M

23.6 M

Slightly volatile

Inventory

3.4 M

3.2 M

1.3 M

Slightly volatile

Other Stockholder Equity

278.1 M

264.9 M

88.6 M

Slightly volatile

Total Liabilities

92.4 M

88 M

23 M

Slightly volatile

Property Plant And Equipment Gross

9.5 M

9.1 M

1.9 M

Slightly volatile

Total Current Assets

58.8 M

56 M

16.6 M

Slightly volatile

Short Term Debt

10.8 M

10.3 M

2.3 M

Slightly volatile

Common Stock

353.1 K

486.4 K

328.3 K

Slightly volatile

Short and Long Term Debt

10.2 M

9.7 M

2 M

Slightly volatile

Other Liabilities

1.2 M

687.5 K

Slightly volatile

Capital Stock

462.2 K

486.5 K

1.2 M

Slightly volatile

Non Current Liabilities Other

85.5 K

90 K

476.7 K

Slightly volatile

Intangible Assets

19.1 M

18.2 M

5.5 M

Slightly volatile

Capital Lease Obligations

8.2 M

7.8 M

1.6 M

Slightly volatile

Property Plant Equipment

759.2 K

547.9 K

307.8 K

Slightly volatile

Warrants

4.5 M

5.3 M

4 M

Slightly volatile

Capital Surpluse

154.5 M

205.9 M

112.8 M

Slightly volatile

Preferred Stock Total Equity

112

126

138

Slightly volatile

Long Term Debt

11.1 M

8.9 M

16.5 M

Slightly volatile

Good Will

1.6 T

1.8 T

2 T

Slightly volatile

LifeMD Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

11.5 M

10.9 M

2.5 M

Slightly volatile

Interest Expense

2.6 M

2.5 M

1 M

Slightly volatile

Selling General Administrative

87.7 M

83.6 M

26 M

Slightly volatile

Total Revenue

256.5 M

244.3 M

67.7 M

Slightly volatile

Gross Profit

227.5 M

216.6 M

58.6 M

Slightly volatile

Other Operating Expenses

276 M

262.9 M

81.5 M

Slightly volatile

Cost Of Revenue

29.1 M

27.7 M

9.1 M

Slightly volatile

Total Operating Expenses

247 M

235.2 M

72.4 M

Slightly volatile

Selling And Marketing Expenses

124.4 M

118.5 M

37.8 M

Slightly volatile

Research Development

11.5 M

10.9 M

2.5 M

Slightly volatile

Discontinued Operations

1.1 M

585.2 K

Slightly volatile

Reconciled Depreciation

11.5 M

10.9 M

2.6 M

Slightly volatile

Preferred Stock And Other Adjustments

2.3 M

2.8 M

4 M

Slightly volatile

Non Recurring

3 M

3.4 M

3.7 M

Slightly volatile

LifeMD Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Stock Based Compensation

14.8 M

14.1 M

5.9 M

Slightly volatile

Depreciation

11.5 M

10.9 M

2.6 M

Slightly volatile

End Period Cash Flow

42.3 M

40.3 M

12.2 M

Slightly volatile

Begin Period Cash Flow

40 M

38.1 M

9.9 M

Slightly volatile

Change To Netincome

11.3 M

20.6 M

8.4 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

1.05

1.1

3.4405

Slightly volatile

Dividend Yield

0.0138

0.0137

0.0118

Slightly volatile

Days Sales Outstanding

22.78

16.24

20.3972

Slightly volatile

Average Payables

12.8 M

12.2 M

5.1 M

Slightly volatile

Stock Based Compensation To Revenue

0.0629

0.0662

0.169

Slightly volatile

Capex To Depreciation

1.52

1.09

1.1226

Slightly volatile

EV To Sales

1.0

1.05

3.3973

Slightly volatile

Inventory Turnover

4.22

7.74

5.2931

Slightly volatile

Days Of Inventory On Hand

46.35

48.79

93.5979

Slightly volatile

Payables Turnover

1.27

1.35

1.536

Pretty Stable

Sales General And Administrative To Revenue

0.37

0.39

0.7863

Slightly volatile

Average Inventory

3.1 M

2.9 M

1.3 M

Slightly volatile

Research And Ddevelopement To Revenue

0.0423

0.0403

0.0231

Slightly volatile

Capex To Revenue

0.0372

0.0489

0.0278

Slightly volatile

Cash Per Share

0.8

0.76

0.3509

Slightly volatile

Days Payables Outstanding

305

279

280

Pretty Stable

Intangibles To Total Assets

0.19

0.2

0.3026

Slightly volatile

Current Ratio

0.85

0.73

0.9774

Pretty Stable

Receivables Turnover

33.46

23.27

38.9822

Pretty Stable

Capex Per Share

0.15

0.25

0.0963

Slightly volatile

Average Receivables

6.4 M

6.1 M

1.9 M

Slightly volatile

Revenue Per Share

4.87

4.64

1.962

Slightly volatile

Interest Debt Per Share

0.63

0.6

0.2048

Slightly volatile

Debt To Assets

0.24

0.4

0.2572

Pretty Stable

Operating Cycle

61.77

65.02

114

Slightly volatile

Days Of Payables Outstanding

305

279

280

Pretty Stable

Ebt Per Ebit

0.78

1.02

0.9558

Slightly volatile

Long Term Debt To Capitalization

1.23

2.02

1.0122

Slightly volatile

Quick Ratio

0.63

0.69

0.7315

Pretty Stable

Net Income Per E B T

0.74

0.93

0.9186

Pretty Stable

Cash Ratio

0.41

0.52

0.4773

Slightly volatile

Days Of Inventory Outstanding

46.35

48.79

93.5979

Slightly volatile

Days Of Sales Outstanding

22.78

16.24

20.3972

Slightly volatile

Free Cash Flow Operating Cash Flow Ratio

0.37

0.39

0.9315

Slightly volatile

Fixed Asset Turnover

23.05

24.27

185

Very volatile

Debt Ratio

0.24

0.4

0.2572

Pretty Stable

Price Sales Ratio

1.05

1.1

3.4405

Slightly volatile

Asset Turnover

2.54

2.64

3.0499

Very volatile

Gross Profit Margin

0.62

0.8

0.7639

Slightly volatile

LifeMD Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

265.6 M

253 M

88.5 M

Slightly volatile

Enterprise Value

252.2 M

240.2 M

82 M

Slightly volatile

LifeMD Fundamental Market Drivers

	Forward Price Earnings	14.7275
	Cash And Short Term Investments	35 M

LifeMD Upcoming Events

	27th of March 2024 Upcoming Quarterly Report	View
	10th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	27th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About LifeMD Financial Statements

LifeMD stakeholders use historical fundamental indicators, such as LifeMD's revenue or net income, to determine how well the company is positioned to perform in the future. Although LifeMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in LifeMD's assets and liabilities are reflected in the revenues and expenses on LifeMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LifeMD Inc. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Current Deferred Revenue	16.7 M	17.5 M
Total Revenue	244.3 M	256.5 M
Cost Of Revenue	27.7 M	29.1 M
Stock Based Compensation To Revenue	0.07	0.06
Sales General And Administrative To Revenue	0.39	0.37
Research And Ddevelopement To Revenue	0.04	0.04
Capex To Revenue	0.05	0.04
Revenue Per Share	4.64	4.87
Ebit Per Revenue	(0.07)	(0.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

JBL	Jabil Circuit
MRK	Merck Company
AMGN	Amgen Inc

When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:

How To Invest In LifeMD

Details

Is LifeMD Stock a good investment?

Details

What is LifeMD's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of LifeMD Correlation against competitors.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.25)

Revenue Per Share

5.686

Quarterly Revenue Growth

0.13

Return On Assets

(0.03)

Return On Equity

(22.43)

The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

LifeMD Financial Statements From 2010 to 2026

LifeMD Total Revenue

256.54 Million

LifeMD Balance Sheet

LifeMD Income Statement

LifeMD Cash Flow Statement

Financial Ratios

LifeMD Valuation Data

LifeMD Fundamental Market Drivers

LifeMD Upcoming Events

About LifeMD Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY